公开(公告)号：KR1020130028012A

公开(公告)日：2013-03-18

申请号：KR1020120099149

申请日：2012-09-07

Applicant: 신풍제약주식회사

Inventor： 조일환 ,  황의진 ,  서무석 ,  박영수 ,  김봉주 ,  김형준

IPC: A61K31/728 ,  A61K9/06 ,  A61K9/08 ,  A61P19/02

CPC classification number: A61K9/0019 ,  A61K31/728 ,  A61K31/738 ,  A61K47/36

Abstract: PURPOSE: A therapeutic injection agent for arthritis is provided to ensure excellent physical property and long-term persistence. CONSTITUTION: A therapeutic injection agent for treating or relieving arthritis contains 0.4-3.0 (w/w)% of hydrogel which is prepared by crosslinking of hyaluronic acid and alkylene diamine. The alkylene diamine is hexamethylene diamine. The composition further contains hyaluronic acid.

Abstract translation: 目的：提供用于关节炎的治疗注射剂，以确保优异的物理性能和长期持久性。 构成：用于治疗或缓解关节炎的治疗注射剂含有通过透明质酸和亚烷基二胺的交联制备的0.4-3.0（w / w）％的水凝胶。 亚烷基二胺是六亚甲基二胺。 组合物还含有透明质酸。